Equities

Daxor Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
DXR:NAQ

Daxor Corp

Actions
FinancialsClosed End Investments
  • Price (USD)12.59
  • Today's Change0.391 / 3.20%
  • Shares traded34.28k
  • 1 Year change+74.39%
  • Beta0.0335
Data delayed at least 15 minutes, as of Feb 11 2026 20:56 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Daxor Corporation is a diversified, closed-end management investment company. Its focus and operations are as a medical device manufacturing, company. It specializes in blood volume measurement technology focused on blood volume testing innovation. It markets the Blood Volume Analyzer (BVA)-100, the diagnostic blood test cleared by the FDA to provide objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000 tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a range of surgical and medical conditions, including reducing mortality and readmissions in heart failure and critical care. Its facility provides on-demand, next day blood volume analysis results. It has several ongoing trials in the areas of heart failure treatment with support from the NIH and is under contract developing analyzers to improve combat casualty care with the United States Department of Defense.

  • Revenue in USD (TTM)66.31k
  • Net income in USD1.80m
  • Incorporated1971
  • Employees37.00
  • Location
    Daxor Corp107 Meco LaneOAK RIDGE 37830United StatesUSA
  • Phone+1 (865) 425-0555
  • Fax+1 (212) 244-0806
  • Websitehttps://www.daxor.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Ribbon Acquisition Corp0.00569.30k67.68m--111.530.2654----0.09380.09380.0039.420.00------2.20--2.22--------------0.00--------------
Great Elm Group Inc23.11m3.22m67.78m50.0014.460.900211.322.93-0.1514-0.15140.59292.300.1582--5.26462,240.003.200.16173.550.192115.7232.7820.211.17----0.4242---8.51-22.671,018.16---12.59--
International Media Acquisition Corp0.00-199.50k68.30m-----------0.0291-0.02910.00-1.720.00-------2.57--------------------------49.89------
Daxor Corp66.31k1.80m71.09m37.0029.871.71--1,072.120.40840.40840.01337.150.0019--4.20--5.126.845.267.28-1,927.96-365.372,710.68854.81----0.0073---26.75-20.6391.11------
Invesco High Income Trust II-100.00bn-100.00bn71.54m--------------------------------------------------------------
MainStreetChamber Holdings Inc0.00-864.62k71.84m0.00---------0.0985-0.09850.00-0.06050.00-------4,093.26-863.98---------------4.42--------87.21------
Eaton Vance California Muncpl Incme Trst-100.00bn-100.00bn73.15m0.00------------------------------------------------------------
TLGY Acquisition Corp0.00-26.71m73.35m0.00---------4.38-4.380.00-4.670.00-------106.15---133.62-------------0.0492---------42.36------
European Equity Fund Inc2.14m9.89m73.38m--7.440.9053--34.241.471.470.319912.050.0278--4.56--12.843.5512.903.7058.7357.52461.61135.01----0.00144.9015.761.01-116.57----13.04
AI Technology Group Inc.-100.00bn-100.00bn73.91m3.00--2.22----------1.13------------------------8.45--0.00-------56.23------
Nuveen Minnesota Qulty Mnicpal Incm Fund4.94m576.79k74.28m--104.781.01--15.040.11540.11540.792511.980.0394--2.56--0.4602-0.15080.4664-0.152243.8447.0811.68-4.58--1.390.4034--23.11-1.33-113.81----56.65
Wintergreen Acquisition Corp-100.00bn-100.00bn74.64m----1.28----------7.98----------------------------0.00--------------
Data as of Feb 11 2026. Currency figures normalised to Daxor Corp's reporting currency: US Dollar USD

Institutional shareholders

1.71%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 202547.98k0.97%
Renaissance Technologies LLCas of 30 Sep 202528.92k0.58%
Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Sep 20253.54k0.07%
SBI Securities Co., Ltd.as of 31 Dec 20253.13k0.06%
Vanguard Fiduciary Trust Co.as of 31 Dec 20251.05k0.02%
UBS Securities LLCas of 31 Dec 202590.000.00%
BofA Securities, Inc.as of 30 Sep 202540.000.00%
JPMorgan Securities LLC (Investment Management)as of 30 Sep 20254.000.00%
Keyes, Stange & Wooten Wealth Management LLCas of 30 Sep 20250.000.00%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.